Glutamate Carboxypeptidase II (GCPII)-Targeted PET to Identify Muscle Denervation in Peripheral Nervous System Injuries
This study demonstrates that GCPII-targeted PET imaging using FDA-approved agents can noninvasively detect and monitor muscle denervation and reinnervation in peripheral nerve injuries by exploiting the persistent overexpression of GCPII in denervated muscles, offering a promising alternative to invasive electromyography.